Related Experiment Videos
Methodological issues in developing new acute treatments for patients with bipolar illness
A J Rush1, R M Post, W A Nolen
1Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas 75390-9086, USA.
Biological Psychiatry
|October 6, 2000
Summary
Developing new treatments for bipolar disorder faces challenges with traditional research methods. This review examines these obstacles and proposes solutions for more effective clinical trials in mental health.
Area of Science:
- Psychiatry and Neurology
- Mental Health Treatment Development
- Clinical Trial Methodology
Background:
- The National Institute of Mental Health (NIMH) aims to expedite new treatments for severe mental illnesses like bipolar disorder.
- Traditional efficacy trial designs, prioritizing internal validity, present challenges for bipolar disorder research.
- Past conferences and literature reviews highlight issues in developing effective acute treatments for bipolar disorder.
Purpose of the Study:
- To identify common problems in the development and evaluation of acute treatments for bipolar disorder.
- To propose solutions and alternative designs for improving efficacy trials in bipolar disorder.
- To facilitate the establishment of efficacy, safety, and comparative value of different bipolar disorder treatments.
Main Methods:
- Review of existing literature in neurology and psychiatry.
- Analysis of discussions from MacArthur Foundation and NIMH-sponsored conferences (1989, 1992, 1994).
- Examination of assumptions underlying traditional efficacy trial designs.
Main Results:
- Traditional efficacy trials face specific obstacles when applied to bipolar disorder research.
- Several common problems in developing and evaluating acute treatments for bipolar disorder were outlined.
- Potential solutions and alternative trial designs were suggested to address these impediments.
Conclusions:
- Revising traditional efficacy trial methodologies is crucial for advancing bipolar disorder treatment development.
- Alternative study designs can better assess the efficacy, safety, and comparative value of treatments.
- Streamlining treatment development requires addressing the unique challenges in studying severe mental illnesses like bipolar disorder.